Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Revenue forecast

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 19, 2024 2:07pm

111 Views

Post# 35887759

RE:RE:RE:RE:RE:Revenue forecast

Alternative view. The $21M revenue includes starter kits (serum, 0.5% cream, 0.2% cream) and reorders for maintenance (0.2% cream)

2025	Starter Kit	70% Reorder	Starter rev @ $300	Reorder rev @ $100/mo	Total Revenue
January	1,550		465,000		465,000
February	1,938		581,250		581,250
March	2,422		726,563		726,563
April	1,942	1085	582,703	108,500	691,203
May	2,428	1356	728,379	135,625	864,004
June	3,035	1695	910,474	169,531	1,080,005
July	4,553	1360	1,365,942	135,964	1,501,906
August	5,691	1700	1,707,428	169,955	1,877,383
September	7,114	2124	2,134,284	212,444	2,346,728
October	8,361	3187	2,508,361	318,720	2,827,080
November	10,452	3984	3,135,451	398,400	3,533,850
December	13,064	4980	3,919,313	498,000	4,417,313
	62,550	21,471	18,765,147	2,147,139	20,912,285